To assess molecular evolution of the respiratory syncytial virus (RSV) fusion gene, we analyzed RSV-positive specimens from 123 children in Canada who did or did not receive RSV immunoprophylaxis (palivizumab) during 2006-2010. Resistance-conferring mutations within the palivizumab binding site occurred in 8.7% of palivizumab recipients and none of the nonrecipients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310097 | PMC |
| http://dx.doi.org/10.3201/eid1801.110515 | DOI Listing |
Publication Analysis
Top Keywords
molecular evolution
8
evolution respiratory
8
respiratory syncytial
8
syncytial virus
8
fusion gene
8
virus fusion
4
gene canada
4
canada 2006-2010
4
2006-2010 assess
4
assess molecular
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!